Platelet-derived ERp57 mediates platelet incorporation into a growing thrombus by regulation of the αIIbβ3 integrin

Blood

Volumn 122, Issue 22, 2013, Pages 3642-3650

  Wang, Lu ^a   Wu, Yi ^a,b   Zhou, Junsong ^a   Ahmad, Syed S ^b   Mutus, Bulent ^c   Garbi, Natalio ^d   Hämmerling, Günter ^e   Liu, Junling ^f   Essex, David W ^b  

^a SOOCHOW UNIVERSITY   (China)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WINDSOR   (Canada)

^d UNIVERSITY OF BONN   (Germany)

^e GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^f SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALEXA 488; ALPHA2BETA3 INTEGRIN; ERP57 PROTEIN; FLUORESCENT DYE; INTEGRIN; MANGANESE; MUTANT PROTEIN; PROTEIN DISULFIDE ISOMERASE; THROMBIN; UNCLASSIFIED DRUG; FIBRINOGEN RECEPTOR; PDIA3 PROTEIN, HUMAN; PDIA3 PROTEIN, MOUSE; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING TIME; CAROTID ARTERY THROMBOSIS; CHEMICAL LABELING; ENZYME ACTIVE SITE; ENZYME ACTIVITY; FERRIC CHLORIDE-INDUCED THROMBOSIS; GENE SILENCING; HEMOSTASIS; HUMAN; MEGAKARYOCYTE; MESENTERIC ARTERY OCCLUSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; REGULATORY MECHANISM; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTE MEMBRANE; THROMBOCYTOPOIESIS; 129 MOUSE; ANIMAL; BLOOD; C57BL MOUSE; DEFICIENCY; ENZYMOLOGY; GENETICS; KNOCKOUT MOUSE; PHYSIOLOGY; SITE DIRECTED MUTAGENESIS; THROMBOCYTE; THROMBOSIS;

ANIMALS; BLOOD PLATELETS; CATALYTIC DOMAIN; HUMANS; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; MUTAGENESIS, SITE-DIRECTED; MUTANT PROTEINS; PLATELET ACTIVATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROTEIN DISULFIDE-ISOMERASES; RECOMBINANT PROTEINS; THROMBOSIS;

EID: 84888229791     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-06-506691     Document Type: Article

References (48)

1. Hatahet F, Ruddock LW. Protein disulfide isomerase: a critical evaluation of its function in disulfide bond formation. Antioxid Redox Signal. 2009;11(11):2807-2850.
2. Essex DW. Redox control of platelet function. Antioxid Redox Signal. 2009;11(5):1191-1225.
3. Essex DW, Li M. Protein disulphide isomerase mediates platelet aggregation and secretion. Br J Haematol. 1999;104(3):448-454.
4. Lahav J, Gofer-Dadosh N, Luboshitz J, Hess O, Shaklai M. Protein disulfide isomerase mediates integrin-dependent adhesion. FEBS Lett. 2000; 475(2):89-92.
5. Lahav J, Jurk K, Hess O, et al. Sustained integrin ligation involves extracellular free sulfhydryls and enzymatically catalyzed disulfide exchange. Blood. 2002;100(7): 2472-2478.
6. Lahav J, Wijnen EM, Hess O, et al. Enzymatically catalyzed disulfide exchange is required for platelet adhesion to collagen via integrin alpha2beta1. Blood. 2003;102(6): 2085-2092.
7. Root P, Sliskovic I, Mutus B. Platelet cell-surface protein disulphide-isomerase mediated Snitrosoglutathione consumption. Biochem J. 2004; 382(Pt 2):575-580.
8. Jordan PA, Stevens JM, Hubbard GP, et al. A role for the thiol isomerase protein ERP5 in platelet function. Blood. 2005;105(4):1500-1507.
9. Cho J, Furie BC, Coughlin SR, Furie B. A critical role for extracellular protein disulfide isomerase during thrombus formation in mice. J Clin Invest. 2008;118(3):1123-1131.
10. Reinhardt C, von Brühl ML, Manukyan D, et al. Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activation. J Clin Invest. 2008; 118(3):1110-1122.
11. Holbrook LM, Sasikumar P, Stanley RG, Simmonds AD, Bicknell AB, Gibbins JM. The platelet-surface thiol isomerase enzyme ERp57 modulates platelet function. J Thromb Haemost. 2012;10(2):278-288.
12. Wu Y, Ahmad SS, Zhou J, Wang L, Cully MP, Essex DW. The disulfide isomerase ERp57 mediates platelet aggregation, hemostasis, and thrombosis. Blood. 2012;119(7):1737-1746.
13. Jasuja R, Furie B, Furie BC. Endotheliumderived but not platelet-derived protein disulfide isomerase is required for thrombus formation in vivo. Blood. 2010;116(22):4665-4674.
14. Kim K, Hahm E, Li J, et al. Platelet protein disulfide isomerase is required for thrombus formation but not for hemostasis in mice. Blood. 2013;122(6):1052-1061.
15. Coe H, Michalak M. ERp57, a multifunctional endoplasmic reticulum resident oxidoreductase. Int J Biochem Cell Biol. 2010;42(6):796-799.
16. Li Z, Delaney MK, O'Brien KA, Du X. Signaling during platelet adhesion and activation. Arterioscler Thromb Vasc Biol. 2010;30(12): 2341-2349.
17. Smyth SS, Woulfe DS, Weitz JI, et al; 2008 Platelet Colloquium Participants. G-proteincoupled receptors as signaling targets for antiplatelet therapy. Arterioscler Thromb Vasc Biol. 2009;29(4):449-457.
18. Shattil SJ, Kim C, Ginsberg MH. The final steps of integrin activation: the end game. Nat Rev Mol Cell Biol. 2010;11(4):288-300.
19. Garbi N, Tanaka S, Momburg F, Hämmerling GJ. Impaired assembly of the major histocompatibility complex class I peptide-loading complex in mice deficient in the oxidoreductase ERp57. Nat Immunol. 2006;7(1):93-102.
20. Tiedt R, Schomber T, Hao-Shen H, Skoda RC. Pf4-Cre transgenic mice allow the generation of lineage-restricted gene knockouts for studying megakaryocyte and platelet function in vivo. Blood. 2007;109(4):1503-1506.
21. Hodivala-Dilke KM, McHugh KP, Tsakiris DA, et al. Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J Clin Invest. 1999; 103(2):229-238.
22. Mukai Y, Rikitake Y, Shiojima I, et al. Decreased vascular lesion formation in mice with inducible endothelial-specific expression of protein kinase Akt. J Clin Invest. 2006;116(2):334-343.
23. Wu Y, Suzuki-Inoue K, Satoh K, et al. Role of Fc receptor gamma-chain in platelet glycoprotein Ib-mediated signaling. Blood. 2001;97(12): 3836-3845.
24. Wu Y, Asazuma N, Satoh K, et al. Interaction between von Willebrand factor and glycoprotein Ib activates Src kinase in human platelets: role of phosphoinositide 3-kinase. Blood. 2003;101(9): 3469-3476.
25. Essex DW, Li M, Miller A, Feinman RD. Protein disulfide isomerase and sulfhydryl-dependent pathways in platelet activation. Biochemistry. 2001;40(20):6070-6075.
26. Raturi A, Mutus B. Characterization of redox state and reductase activity of protein disulfide isomerase under different redox environments using a sensitive fluorescent assay. Free Radic Biol Med. 2007;43(1):62-70.
27. Barr JD, Chauhan AK, Schaeffer GV, Hansen JK, Motto DG. Red blood cells mediate the onset of thrombosis in the ferric chloride murine model. Blood. 2013;121(18):3733-3741.
28. Stolla M, Stefanini L, Roden RC, et al. The kinetics of αIIbβ3 activation determines the size and stability of thrombi in mice: implications for antiplatelet therapy. Blood. 2011;117(3): 1005-1013.
29. Léon C, Eckly A, Hechler B, et al. Megakaryocyte-restricted MYH9 inactivation dramatically affects hemostasis while preserving platelet aggregation and secretion. Blood. 2007;110(9):3183-3191.
30. Hitchcock IS, Fox NE, Prévost N, Sear K, Shattil SJ, Kaushansky K. Roles of focal adhesion kinase (FAK) in megakaryopoiesis and platelet function: studies using a megakaryocyte lineage specific FAK knockout. Blood. 2008;111(2):596-604.
31. Mitsios JV, Prevost N, Kasirer-Friede A, et al. What is vinculin needed for in platelets? J Thromb Haemost. 2010;8(10):2294-2304.
32. Petrich BG, Marchese P, Ruggeri ZM, et al. Talin is required for integrin-mediated platelet function in hemostasis and thrombosis. J Exp Med. 2007; 204(13):3103-3111.
33. Soldà T, Garbi N, Hämmerling GJ, Molinari M. Consequences of ERp57 deletion on oxidative folding of obligate and facultative clients of the calnexin cycle. J Biol Chem. 2006;281(10): 6219-6226.
34. Jasuja R, Sharda AV, Kim SH, Furie B, Furie BC. Endothelium but not platelet derived thiol isomerase ERp57 is required for thrombosis in vivo. J Thromb Haemost. 2013;11(suppl 2):202.
35. Ioannou Y, Zhang JY, Passam FH, et al. Naturally occurring free thiols within beta 2-glycoprotein I in vivo: nitrosylation, redox modification by endothelial cells, and regulation of oxidative stress-induced cell injury. Blood. 2010;116(11): 1961-1970.
36. Hotchkiss KA, Matthias LJ, Hogg PJ. Exposure of the cryptic Arg-Gly-Asp sequence in thrombospondin-1 by protein disulfide isomerase. Biochim Biophys Acta. 1998;1388(2):478-488.
37. Jasuja R, Furie B, Furie BC. Endothelial cell thiol isomerase: potential role in thrombus formation [abstract]. Blood. 2007;110(111). Abstract 3709.
38. Litvinov RI, Nagaswami C, Vilaire G, Shuman H, Bennett JS, Weisel JW. Functional and structural correlations of individual alphaIIbbeta3 molecules. Blood. 2004;104(13):3979-3985.
39. Xiao T, Takagi J, Coller BS, Wang JH, Springer TA. Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics. Nature. 2004;432(7013):59-67.
40. Holbrook LM, Watkins NA, Simmonds AD, Jones CI, Ouwehand WH, Gibbins JM. Platelets release novel thiol isomerase enzymes which are recruited to the cell surface following activation. Br J Haematol. 2010;148(4):627-637.
41. Bennett JS, Vilaire G. Exposure of platelet fibrinogen receptors by ADP and epinephrine. J Clin Invest. 1979;64(5):1393-1401.
42. Raturi A, Miersch S, Hudson JW, Mutus B. Platelet microparticle-associated protein disulfide isomerase promotes platelet aggregation and inactivates insulin. Biochim Biophys Acta. 2008; 1778(12):2790-2796.
43. Jurk K, Lahav J, VAN Aken H, Brodde MF, Nofer JR, Kehrel BE. Extracellular protein disulfide isomerase regulates feedback activation of platelet thrombin generation via modulation of coagulation factor binding. J Thromb Haemost. 2011;9(11):2278-2290.
44. Yan B, Hu DD, Knowles SK, Smith JW. Probing chemical and conformational differences in the resting and active conformers of platelet integrin alpha(IIb)beta(3). J Biol Chem. 2000;275(10): 7249-7260.
45. Manickam N, Sun X, Li M, Gazitt Y, Essex DW. Protein disulphide isomerase in platelet function. Br J Haematol. 2008;140(2):223-229.
46. Kamata T, Ambo H, Puzon-McLaughlin W, et al. Critical cysteine residues for regulation of integrin alphaIIbbeta3 are clustered in the epidermal growth factor domains of the beta3 subunit. Biochem J. 2004;378(Pt 3):1079-1082.
47. Mor-Cohen R, Rosenberg N, Landau M, Lahav J, Seligsohn U. Specific cysteines in beta3 are involved in disulfide bond exchange-dependent and -independent activation of alphaIIbbeta3. J Biol Chem. 2008;283(28):19235-19244.
48. Mor-Cohen R, Rosenberg N, Einav Y, et al. Unique disulfide bonds in epidermal growth factor (EGF) domains of β3 affect structure and function of αIIbβ3 and αvβ3 integrins in different manner. J Biol Chem. 2012;287(12):8879-8891.